Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.230 (29.87%)
Aug 17, 2026, 11:22 AM EST
Nuo Therapeutics Market Cap
Nuo Therapeutics has a market cap or net worth of $48.41 million as of August 18, 2026. Its market cap has decreased by -41.89% in one year.
Market Cap
48.41M
Enterprise Value
49.77M
Revenue
5.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
ChartMarket Cap Chart
Since February 14, 2017, Nuo Therapeutics's market cap has increased from 19.85M to 48.41M, an increase of 143.82%. That is a compound annual growth rate of 9.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 48.41M | -49.00% |
| Dec 31, 2025 | 94.91M | 44.81% |
| Dec 31, 2024 | 65.54M | 169.36% |
| Dec 29, 2023 | 24.33M | -61.19% |
| Dec 23, 2022 | 62.70M | 360.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 72.50M |
| Arch Biopartners | 56.03M |
| Vicapsys Life Sciences | 46.94M |
| Biomind Labs | 46.54M |
| Cell Source | 40.76M |
| ProText Mobility | 34.29M |
| BetterLife Pharma | 32.91M |
| EOM Pharmaceuticals Holdings | 25.30M |